UBS Group’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $8.87K | Sell |
|
|||||
|
2024
Q1 | $18.2K | Buy |
|
|||||
|
2023
Q4 | $10.7K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $67.2K | Buy |
|
|||||
|
2023
Q1 | $16.6K | Sell |
|
|||||
|
2022
Q4 | $63.7K | Buy |
|
|||||
|
2022
Q3 | $34K | Buy |
|
|||||
|
2022
Q2 | $11K | Sell |
|
|||||
|
2022
Q1 | $59K | Buy |
|
|||||
|
2021
Q4 | $9K | Sell |
|
|||||
|
2021
Q3 | $80K | Buy |
|
|||||
|
2021
Q2 | $20K | Sell |
|
|||||
|
2021
Q1 | $51K | Buy |
|
|||||
|
2020
Q4 | $40K | Buy |
|
|||||
|
2020
Q3 | $9K | Buy |
|